BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 9108848)

  • 21. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory committee (ACIP).
    MMWR Recomm Rep; 1991 Aug; 40(RR-10):1-28. PubMed ID: 1865873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization of children with pertussis toxoid decreases spread of pertussis within the family.
    Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    Pediatr Infect Dis J; 1998 Mar; 17(3):196-9. PubMed ID: 9535245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extensive swelling reaction associated with diphtheria and tetanus toxoids and acellular pertussis vaccine.
    Sekaran NK; Edwards KM
    Pediatr Infect Dis J; 2006 Apr; 25(4):374-5. PubMed ID: 16567996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pertussis Vaccine Study Group.
    Heininger U; Cherry JD; Stehr K; Schmitt-Grohé S; Uberall M; Laussucq S; Eckhardt T; Meyer M; Gornbein J
    Pediatrics; 1998 Sep; 102(3 Pt 1):546-53. PubMed ID: 9738175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
    MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
    Halperin SA; King J; Law B; Mills E; Willems P
    Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
    Bernbaum J; Daft A; Samuelson J; Polin RA
    Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a two-component acellular pertussis vaccine in infants.
    Liese JG; Meschievitz CK; Harzer E; Froeschle J; Hosbach P; Hoppe JE; Porter F; Stojanov S; Niinivaara K; Walker AM; Belohradsky BH
    Pediatr Infect Dis J; 1997 Nov; 16(11):1038-44. PubMed ID: 9384336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
    Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
    Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [STATISTICO-CLINICAL DATA ON THE USE OF THE COMBINED DIPHTHERIA-PERTUSSIS-TETANUS-POLIOVIRUS VACCINE IN INFANTS].
    GIURANNA U
    Pediatria (Napoli); 1963; 71():962-7. PubMed ID: 14125501
    [No Abstract]   [Full Text] [Related]  

  • 31. Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose.
    Trollfors B; Knutsson N; Taranger J; Mark A; Bergfors E; Sundh V; Lagergård T
    Eur J Pediatr; 2006 Jan; 165(1):14-8. PubMed ID: 16249929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB
    Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of a diphtheria and tetanus toxoids and bicomponent acellular pertussis vaccine with diphtheria and tetanus toxoids and whole-cell pertussis vaccine in infants.
    Pichichero ME; Francis AB; Marsocci SM; Green JL; Disney FA
    Am J Dis Child; 1993 Mar; 147(3):295-9. PubMed ID: 8438811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimated effects of a delay in the recommended vaccination schedule for diphtheria and tetanus toxoids and pertussis vaccine.
    Funkhouser AW; Wassilak SG; Orenstein WA; Hinman AR; Mortimer EA
    JAMA; 1987 Mar; 257(10):1341-6. PubMed ID: 3493356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leads from the MMWR. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures.
    JAMA; 1985 Aug 23-30; 254(8):1009-11, 1014-6. PubMed ID: 3874970
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants.
    Lang J; Duong GH; Nguyen VG; Le TT; Nguyen CV; Kesmedjian V; Plotkin SA
    Lancet; 1997 Jun; 349(9066):1663-5. PubMed ID: 9186385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children.
    Mortimer EA; Kimura M; Cherry JD; Kuno-Sakai H; Stout MG; Dekker CL; Hayashi R; Miyamoto Y; Scott JV; Aoyama T
    Am J Dis Child; 1990 Aug; 144(8):899-904. PubMed ID: 2378338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experience of the People's Republic of Bulgaria in controlling diphtheria, tetanus and whooping cough].
    Polikar ACh; Solomonova KM; Mikhaĭlova VP
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):92-6. PubMed ID: 3874506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [THE EPIDEMIOLOGICAL EFFICACY OF PERTUSSIS-DIPHTHERIA-TETANUS VACCINATION].
    GORDINA RV; ZAKHAROVA MS; OSTROUKHOVA DI; KURAGINA RV; KORASHEVICH VP
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Dec; 40():9-13. PubMed ID: 14154144
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.